IP Library Granted Patent US 9,944,592
Granted Patent B2
US 9,944,592 · App. 15/388,870 · Granted Apr 17, 2018

Acyloxyalkyl carbamate prodrugs, methods of synthesis and use

Inventors: Mark A. Gallop (Palo Alto, CA); Fenmei Yao (Mountain View, CA); Maria J. Ludwikow (Cupertino, CA); Thu Phan (Fremont, CA); Ge Peng (Mountain View, CA)
Assignee: XENOPORT, INC.
C07C269/06C07D307/68C07D333/32C07C2101/08C07C2101/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,944,592
App. No.
15/388,870
Granted
Apr 17, 2018
Kind
B2
Abstract

The disclosures herein relate generally to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, pharmaceutical compositions thereof, methods of making prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, methods of using prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof, and pharmaceutical compositions thereof for treating or preventing common diseases and/or disorders such as spasticity and/or acid reflux disease. The disclosures herein also relate to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-chlorophenyl)butanoic acid and analogs thereof which are suitable for oral administration and to sustained release oral dosage forms thereof.

Claims (27)

1. A method of synthesizing a compound of Formula (I) comprising contacting a compound of Formula (II) with a compound of Formula (III):

in the presence of a member of the group selected from an organic base, an inorganic base, and a metal salt, wherein:

the organic base is selected from triethylamine, tributylamine, diisopropylethylamine, dimethylisopropylamine, N-methylmorpholine, N-methylpyrrolidine, N-methylpiperidine, pyridine, 2-methylpyridine, 2,6-dimethylpyridine, 4-dimethylaminopyridine, 1,4-diazobicyclo[2.2.2]octane, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,5-diazabicyclo[4.3.0]undec-7-ene or a combination thereof;

X is fluoro, chloro, bromo or iodo;

R 1 is selected from the group consisting of acyl, substituted acyl, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, cycloalkyl, substituted cycloaklyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl and substituted heteroarylalkyl;

R 2 and R 3 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkoxycarbonyl, substituted alkoxycarboyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, cyloalkyl, substituted cycloalkyl, heteroaryl, substituted heteroaryl, heterarylalkyl and substituted heteroarylalkyl or optionally, R 2 and R 3 together with the carbon atom to which they are bonded from a cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl ring;

R 4 is selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, aryldialkylsilyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl or trialkylsilyl; and

R 5 is 4-cholorophenyl.

2. The method of claim 1 , wherein R 4 is hydrogen.

3. The method of claim 1 , wherein R 1 is selected from C 1-6 alkyl, substituted C 1-6 alkyl, C 3-6 cycloalkyl, phenyl, substituted phenyl, C 7-9 phenylalkyl and pyridyl.

4. The method of claim 1 , wherein R 1 is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, 1,1-dimethoxyethyl, 1,1-diethoxyethyl, phenyl, 4-methoxyphenyl, benzyl, phenethyl, styryl, cyclopropyl, cyclobutyl, cyclopentyl, cyclopentyl, cyclohexyl, 2-pyridyl, 2-pyridyl and 4-pyridyl.

5. The method of claim 1 , wherein R1 is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, 1,1-diethoxyethyl, phenyl, cyclohexyl and 3-pyridyl.

6. The method of claim 1 , wherein R 2 and R 3 are independently selected from hydrogen, C 1-4 alkyl, substituted C 1-4 alkyl, C 1-4 alkoxycarbonyl, C 3-6 cycloalkyl, C 3-6 cycloalkoxycarbonyl, phenyl, substituted phenyl, C 7-9 phenylalkyl and pyridyl.

7. The method of claim 1 , wherein R 2 is selected from hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, cyclopentyl, cyclohexyl, methoxycarbonyl, ethoxycarbonyl, isopropyloxycarbonyl, cyclohexyloxycarbonyl, phenyl, benzyl, penethyl, 2-pyridyl, 3-pyridyl and 4-pyridyl, and R 3 is hydrogen.

8. The method of claim 1 , wherein R 2 is selected from hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, phenyl, or cyclohexyl and R 3 is hydrogen.

9. The method of claim 1 , wherein R 2 is selected from methyl, methoxycarbonyl, ethoxycarbonyl, isopropoxycarbonyl and cyclohexyloxycarbonyl and R3 is methyl.

10. The method of claim 1 , wherein R 4 is selected from hydrogen, C 1-6 alkyl, substituted C 1-6 alkyl, C 3-6 cycloalkyl, phenyl, substituted phenyl, C 7-9 phenylalkyl, substituted C 7-9 phenylalkyl, trialkylsilyl and aryldialkylsilyl.

11. The method of claim 1 , wherein R4 is selected from hydrogen, methyl, ethyl, tert-butyl, allyl, benzyl, 4-methoxybenzyl, diphenylmethyl, triphenylmethyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tert-butyldimethylsilyl and phenyldimethylsily.

12. The method of claim 1 , wherein R 4 is selected from hydrogen, allyl, benzyl and trimethylsilyl.

13. The method of claim 1 , wherein:

R 1 is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, phenyl, cyclohexyl, and 3-pyridyl;

R 2 is selected from hydrogen, methyl, n-propyl, and isopropyl;

R 3 is hydrogen; and

R 4 is hydrogen.

14. The method of claim 1 , wherein R 2 is methyl.

15. The method of claim 1 , wherein R 2 is isopropyl.

16. The method of claim 15 , wherein R 1 is isopropyl.

Assignments (6)
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
SECURITY INTEREST Recorded Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2018
From: XENOPORT, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 046633/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: ARBOR PHARMACEUTICALS, LLC
To: XENOPORT, INC.
Reel/Frame 046449/0306 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2017
From: GALLOP, MARK A.; YAO, FENMEI; LUDWIKOW, MARIA J.; PHAN, THU; PENG, GE
To: XENOPORT, INC.
Reel/Frame 041647/0939 →
Continuity (8)
Continuation 12883860 · Sep 16, 2010
Continuation 12473112 · May 27, 2009
Continuation 11923507 · Oct 24, 2007
Continuation 11508131 · Aug 21, 2006
Continuation 10932374 · Aug 20, 2004
Provisional Application 60496938 · Aug 20, 2003
Provisional Application 60606637 · Aug 13, 2004
Related Publication 20170190657A1 · Jul 6, 2017